← SynDRA
SELTOREXANT
SynDRA canonical compound SYN0038333 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | HCRTR2 |
|---|
| Mechanism of action | orexin receptor antagonist |
|---|
| Indication | depression |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- HCRTR1 ANTAGONIST
- HCRTR2 ANTAGONIST
- orexin receptor antagonist
Cross-references
Synonyms
- JNJ-42847922
- MIN-202
- Seltorexant [USAN]
- SCHEMBL1671257
- GTPL9308
- CHEMBL3597971
- JNJ-922
- SQOCEMCKYDVLMM-UHFFFAOYSA-N
- BDBM118454
- Methanone, (5-(4,6-dimethyl-2-pyrimidinyl)hexahydropyrrolo(3,4-C)pyrrol-2(1H)-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)-
- AKOS032954213
- US8653263, 107
- [2-(4,6-dimethylpyrimidin-2-yl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-[2-fluoro-6-(triazol-2-yl)phenyl]methanone
- ((3aR,6aS)-5-(4,6-dimethylpyrimidin- 2-yl)hexahydropyrrolo(3,4-c)pyrrol-2(1H)-yl)(2
- Min-202
- RefChem:403624
- Seltorexant (USAN/INN)
- C21H22FN7O
- orb1309112
- orb3033067
- SCHEMBL29614942
- EX-A4759
- EBC-29044
- MFCD31700700
- SB19652
- T12877L
- JNJ42847922
- AC-36998
- DA-57786
- MS-26993
- HY-109012
- CS-0030510
- D11269
- E77321
- EN300-22831084
Look up SELTOREXANT in the interactive SynDRA portal →